HomeCompareHMTXF vs GBDC

HMTXF vs GBDC: Dividend Comparison 2026

HMTXF yields 4072.49% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HMTXF wins by $8532781060980.36M in total portfolio value
10 years
HMTXF
HMTXF
● Live price
4072.49%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8532781061001.13M
Annual income
$8,139,610,200,782,360,000.00
Full HMTXF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — HMTXF vs GBDC

📍 HMTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHMTXFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HMTXF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HMTXF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMTXF
Annual income on $10K today (after 15% tax)
$346,161.68/yr
After 10yr DRIP, annual income (after tax)
$6,918,668,670,665,005,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, HMTXF beats the other by $6,918,668,670,651,075,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMTXF + GBDC for your $10,000?

HMTXF: 50%GBDC: 50%
100% GBDC50/50100% HMTXF
Portfolio after 10yr
$4266390530510.95M
Annual income
$4,069,805,100,399,374,300.00/yr
Blended yield
95.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

HMTXF
No analyst data
Altman Z
-77.1
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMTXF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHMTXFGBDC
Forward yield4072.49%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$8532781061001.13M$20.78M
Annual income after 10y$8,139,610,200,782,360,000.00$16,389,263.41
Total dividends collected$8505980562203.27M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: HMTXF vs GBDC ($10,000, DRIP)

YearHMTXF PortfolioHMTXF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$417,949$407,249.03$12,490$1,790.28+$405.5KHMTXF
2$16,354,620$15,907,414.89$16,522$3,157.73+$16.34MHMTXF
3$599,244,865$581,745,420.76$23,578$5,898.68+$599.22MHMTXF
4$20,562,279,794$19,921,087,789.34$37,115$11,886.75+$20562.24MHMTXF
5$660,847,691,261$638,846,051,880.89$66,136$26,423.57+$660847.63MHMTXF
6$19,895,674,352,505$19,188,567,322,855.41$137,257$66,491.44+$19895674.22MHMTXF
7$561,191,767,703,669$539,903,396,146,489.40$341,734$194,868.54+$561191767.36MHMTXF
8$14,833,096,999,026,612$14,232,621,807,583,686.00$1,050,788$685,133.02+$14833096997.98MHMTXF
9$367,449,402,073,618,800$351,577,988,284,660,350.00$4,099,314$2,974,971.01+$367449402069.52MHMTXF
10$8,532,781,061,001,133,000$8,139,610,200,782,360,000.00$20,775,530$16,389,263.41+$8532781060980.36MHMTXF

HMTXF vs GBDC: Complete Analysis 2026

HMTXFStock

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

Full HMTXF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this HMTXF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMTXF vs SCHDHMTXF vs JEPIHMTXF vs OHMTXF vs KOHMTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.